4//SEC Filing
Hassard James 4
Accession 0001209191-21-002801
CIK 0000879407other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:05 PM ET
Size
5.7 KB
Accession
0001209191-21-002801
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-01-07$75.00/sh−15,625$1,171,875→ 109,375 total
Footnotes (2)
- [F1]Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
- [F2]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.06, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001799357
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 6:05 PM ET
- Size
- 5.7 KB